Skip to main content

Table 2 Periprosthetic joint infection rates

From: Efficacy of mupirocin, neomycin and octenidine for nasal Staphylococcus aureus decolonisation: a retrospective cohort study

  Group 1 (mupirocin) Group 2 (octenidine) Group 3 (neomycin) Group 4 Total P-Value
MSSA PJI 2/698 (0.29%) 3/1221 (0.25%) 1/1210 (0.08%) 4/1143 (0.35%) 10/4272 (0.23%) 0.452
All PJI 6/698(0.86%) 3/1221 (0.25%) 8/1210 (0.66%) 12/1143 (1.05%) 29/4272 (0.68%) 0.108